Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
Condition: Type1 Diabetes Interventions: Device: HCL; Drug: verapamil 120mg tablet; Device: non-HCL; Drug: placebo Sponsors: Jaeb Center for Health Research; University of Minnesota; Medtronic; Tandem Diabetes Care, Inc.; DexCom, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials